• 1
    Bernardi M, Trevisani F, Santini C, Zoli G, Baraldini M, Ligabue A, Gasbarrini G. Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. HEPATOLOGY 1983; 3: 5664.
  • 2
    Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982; 307: 15521557.
  • 3
    Henriksen JH, Ring-Larsen H, Christensen NJ. Plasma noradrenaline in patients with liver cirrhosis in relation to ascites and treatment. Clin Physiol 1981; (suppl. 1): 6670.
  • 4
    Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ. Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 1983; 5: 552559.
  • 5
    Llach J, Ginès P, Arroyo V, Rimola A, Tito L, Badalamenti S, Jimenez W, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482487.
  • 6
    Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 1988; 6: 350358.
  • 7
    Gaudin C, Braillon A, Moreau R, Roulot D, Bacq Y, Hadengue A, Lebrec D. Relations entre les catécholamines plasmatiques et la sévérité de la maladie du foie et l'hémodynamique des malades atteints de cirrhose. Gastroenterol Clin Biol 1989; 13: 701706.
  • 8
    Henriksen JH, Christensen NJ, Ring-Larsen H. Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis: relation to haemodynamics. Clin Physiol 1981; 1: 293304.
  • 9
    Henriksen JH, Ring-Larsen H, Christensen NJ. Circulating noradrenaline and central haemodynamics in patients with cirrhosis. Scand J Gastroenterol 1985; 20: 11851190.
  • 10
    Bendtsen F, Henriksen JH, Sorensen TIA, Christensen NJ. Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic haemodynamics. J Hepatol 1990; 10: 198204.
  • 11
    Thornton JR, Dean JH, Losowsky MS. Do increased catecholamines and plasma methionine enkephalin in cirrhosis promote bleeding oesophageal varices? Q J Med 1988; 68: 541551.
  • 12
    Braillon A, Moreau R, Hadengue A, Roulot D, Sayegh R, Lebrec D. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension:. effect of propranolol. J Hepatol 1989; 9: 312318.
  • 13
    Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646649.
  • 14
    Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 4357.
  • 15
    Hjemdahl P. Catecholamine measurements by high-performance liquid chromatography. Am J Physiol 1984; 247: E13E20.
  • 16
    Gaudin C, Ruget G, Braillon A, Selz F, Cuche JL, Lebrec D. Portal and arterial free and conjugated noradrenaline in two models of portal hypertension in rats. Life Sci 1989; 45: 13331339.
  • 17
    Kostreva DR, Castaner A, Kampine JP. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol 1980; 238: R390R394.
  • 18
    Kiel JW, Pitts V, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am J Physiol 1985; 248: G192G195.
  • 19
    Bomzon A, Blendis LM. Vascular reactivity in experimental portal hypertension. Am J Physiol 1987; 252: G158G162.
  • 20
    Valla D, Gaudin C, Geoffroy P, Braillon A, Lee SS, Lebrec D. Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol. J Hepatol 1987; 4: 8692.
  • 21
    Vatner DE, Vatner SF, Nejima J, Uemura N, Susanni EE, Hintze TH, Homcy CJ. Chronic norepinephrine elicits desensitization by uncoupling the β-receptor. J Clin Invest 1989; 84: 17411748.